Dr. George Miller signed a Research Collaboration Agreement for $232,000 with GSK to develop RIP1 inhibitors for clinical trial in advanced pancreatic cancer.

Dr. George Miller signed a Research Collaboration Agreement for $232,000 with GSK to develop RIP1 inhibitors for clinical trial in advanced pancreatic cancer.

2017-06-05T00:00:00